Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays

Toxicology in Vitro

Volumn 20, Issue 7, 2006, Pages 1159-1167

  Kim, Hyun Jung ^a   Park, Young In ^a   Dong, Mi Sook ^a  

^a Korea University   (South Korea)

Author keywords

22Rv1; AR mediated reporter gene assay; Dexamethasone; LNCaP; PC3

Indexed keywords

ANDROGEN RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; LUCIFERASE; MESSENGER RNA; PERMETHRIN; PLASMID VECTOR; PYRETHROID; STEROID RECEPTOR; VINCLOZOLIN;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; REPORTER GENE; SCREENING;

ANDROGEN ANTAGONISTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DEXAMETHASONE; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNGICIDES, INDUSTRIAL; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; INSECTICIDES; LUCIFERASES; MALE; OXAZOLES; PROSTATIC NEOPLASMS; PYRETHRINS; RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTIONAL ACTIVATION;

EID: 33746215073     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.03.003     Document Type: Article

References (39)

1. Andersen H.R., Vinggaard A.M., Rasmussen T.H., Gjermandsen I.M., and Bonefeld-Jorgensen E.C. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicology and Applied Pharmacology 179 (2002) 1-12
2. Andrade A.J., Araujo S., Santana G.M., Ohi M., and Dalsenter P.R. Screening for in vivo (anti)estrogenic and (anti)androgenic activities of technical and formulated deltamethrin. Regulatory Toxicology and Pharmacology 35 (2002) 379-382
3. Attardi B.J., Burgenson J., Hild S.A., and Reel J.R. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells. Molecular and Cellular Endocrinology 30 (2004) 121-132
4. Birkhoj M., Nellemann C., Jarfelt K., Jacobsen H., Andersen H.R., Dalgaard M., and Vinggaard A.M. The combined antiandrogenic effects of five commonly used pesticides. Toxicology and Applied Pharmacology 201 (2004) 10-20
5. Borras M., Hardy L., Lempereur F., el Khissiin A.H., Legros N., Gol Winkler R., and Leclercq G. Estradiol-induced down-regulation of estrogen receptor: effect of various modulators of protein synthesis and expression. Journal of Steroid Biochemistry and Molecular Biology 48 (1994) 325-336
6. Cato A., Henderson D., and Ponta H. The hormone response element of the mouse mammary tumor virus mediates the progesterone and androgen induction of transcription in the proviral long terminal repeat region. European Molecular Biology Organization Journal 6 (1987) 363-368
7. Colborn T., vom Saal F.S., and Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspective 101 (1993) 378-384
8. Danzo B.J. The effects of environmental hormones on reproduction. Cellular and Molecular Life Sciences 54 (1998) 1249-1264
9. Darbre P., Page M., and King R.J. Androgen regulation by the long terminal repeat of mouse mammary tumor virus. Molecular and Cellular Biology 6 (1986) 2847-2854
10. Denmeade S.R., Litvinov I., Sokoll L.J., Lilja H., and Isaacs J.T. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo. Prostate 56 (2003) 45-53
11. Garey J., and Wolff M.S. Estrogenic and antiprogestagenic activities of pyrethroid insecticides. Biochemical and Biophysical Research Communications 251 (1998) 855-859
12. Gkonos P.J., Guo F., and Burnstein K.L. Type I vasoactive intestinal peptide receptor expression in PC3/AR cells is evidence of prostate epithelial differentiation. Prostate 42 (2000) 137-144
13. Gowland P.L., and Beutti E. Mutations in the hormone regulatory element of mouse mammary tumor virus differentially affect the response to progestins, androgens, and glucocorticoids. Molecular and Cellular Endocrinology 9 (1989) 3999-4008
14. Hartel A., Didier A., Pfaffl M.W., and Meyer H.H. Characterisation of gene expression patterns in 22Rv1 cells for determination of environmental androgenic/antiandrogenic compounds. Journal of Steroid Biochemistry and Molecular Biology 84 (2003) 231-238
15. Hartig P.C., Bobseine K.L., Britt B.H., Cardon M.C., Lambright C.R., Wilson V.S., and Gray L.E. Development of two androgen receptor assays using adenoviral transduction of MMTV-Luc reporter and/or hAR for endocrine screening. Toxicological Sciences 66 (2002) 82-90
16. Kaighn M.E., Narayan K.S., Ohnuki Y., Lechner J.F., and Jones L.W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investigational Urology 17 (1979) 16-23
17. 5. Mutation Research 545 (2004) 37-47
18. Kelce W.R., Gray L.E., and Wilson E.M. Antiandrogens as environmental endocrine disruptors. Reproduction, Fertility and Development 10 (1998) 105-111
19. Kim S.S., Lee R.D., Lim K.J., Kwack S.J., Rhee G.S., Seok J.H., Lee G.S., An B.S., Jeung E.B., and Park K.L. Potential estrogenic and antiandrogenic effects of permethrin in rats. Journal of Reproduction and Development 51 (2005) 201-210
20. Kojima H., Katsura E., Takeuchi S., Niiyama K., and Kobayashi K. Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environmental Health Perspectives 112 (2004) 524-531
21. Kunimatsu T., Yamada T., Ose K., Sunami O., Kamita Y., Okuno Y., Seki T., and Nakatsuka I. Lack of (anti-) androgenic or estrogenic effects of three pyrethroids (esfenvalerate, fenvalerate, and permethrin) in the Hershberger and uterotrophic assays. Regulatory Toxicology and Pharmacology 35 (2002) 227-237
22. Lee H.J., Lee Y.S., Kwon H.B., and Lee K. Novel yeast bioassay system for detection of androgenic and antiandrogenic compounds. Toxicology in Vitro 17 (2003) 237-244
23. Linja M.J., Savinainen K.J., Tammela T.L., Isola J.J., and Visakorpi T. Expression of ERalpha and ERbeta in prostate cancer. Prostate 15 (2003) 180-186
24. Rajesh K.N. Endocine Disruptors: Effects on Male and Female Reproductive System (1999), CRC Press, LLC, Boca Raton, FL pp. 226-242
25. Roy A.K., and Chaterjee B. Androgen action. Critical Reviews in Eukaryotic Gene Expression 5 (1995) 157-176
26. Roy A.K., Lavrovsky Y., Song C.S., Chen S., Jung M.H., Velu N.K., Bi B.Y., and Chatterjee B. Regulation of androgen action. Vitamins and Hormones 55 (1999) 309-352
27. Sramkoski R.M., Pretlow II T.G., Giaconia J.M., Pretlow T.P., Schwartz S., Sy M.S., Marengo S.R., Rhim J.S., Zhang D., and Jacobberger J.W. A new human prostate carcinoma cell line, 22Rv1. In Vitro Cellular and Developmental Biology 35 (1999) 403-409
28. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., and Paulsom D.F. Isolation of a human prostate carcinoma cell line (DU 145). International Journal of Cancer 21 (1978) 274-281
29. Takahashi T., Hoshi S., Satoh M., Kaneda T., Suzuki K., Nakagawara I., and Orikasa K.I. The study of PSA gene expression on urogenital cell lines. International Journal of Urology 6 (1999) 526-531
30. Tepper C.G., Boucher D.L., Ryan P.E., Ma A.-H., Xia L., Lee L.-F., Pretlow T.G., and Kung H.-J. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Cancer Research 62 (2002) 6606-6614
31. Tessier D.M., and Matsumura F. Increased ErbB-2 tyrosine kinase activity, MAPK phosphorylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicological Sciences 60 (2001) 38-43
32. Veldscholte J., Ris-Stalpers C., Kuiper G.G., Jenster G., Berrevoets C., Claassen E., vanRooij H.C., Trapman J., Brinkmann A.O., and Mulder E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochemical and Biophysical Research Communications 173 (1990) 534-540
33. Villalobos M., Olea N., Brotons J.A., Olea-Serrano M.F., Ruiz de Almodovar J.M., and Pedraza V. The E-screen assay: a comparison of different MCF7 cell stocks. Environmental Health Perspective 103 (1995) 844-850
34. Waghray A., Feroze F., Schober M.S., Yao F., Wood C., Puravs E., Krause M., Hanash S., and Chen Y.Q. Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 1 (2001) 1327-1338
35. Wilson V.S., Bobseine K., Lambright C.R., and Gray Jr. L.E. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicological Sciences 66 (2002) 69-81
36. Wolf C.J., LeBlanc G.A., Ostby J.S., and Gray Jr. L.E. Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicological Sciences 55 (2000) 152-161
37. Wolf C.J., LeBlanc G.A., and Gray Jr. L.E. Interactive effects of vinclozolin and testosterone propionate on pregnancy and sexual differentiation of the male and female SD rat. Toxicological Sciences 78 (2004) 135-143
38. Wong C., Kelce W.R., Sar M., and Wilson E.M. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. Journal of Biological Chemistry 270 (1995) 19998-20003
39. Yamada T., Ueda S., Yoshioka K., Kawamura S., Seki T., Okuno Y., and Mikami N. Lack of estrogenic or (anti-)androgenic effects of d-phenothrin in the uterotrophic and Hershberger assays. Toxicology 186 (2003) 227-239